8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ultraviolet radiation (UVR) contributes to the vast majority of nonmelanoma skin cancer (NMSC). As the incidence of NMSC continues to rise, topical therapies will be used with increasing frequency. Topical therapies may benefit high-risk surgical candidates as an alternative treatment modality and may improve overall cosmesis. The most commonly employed topical therapies are imiquimod, 5-fluorouracil (5-FU), and diclofenac.

          Related collections

          Author and article information

          Journal
          Dermatol Surg
          Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
          1524-4725
          1076-0512
          Jan 2012
          : 38
          : 1
          Affiliations
          [1 ] Heights Dermatology, Houston, Texas 77008, USA. drdesai910@pol.net
          Article
          10.1111/j.1524-4725.2011.02194.x
          22092926
          925177d0-66ec-4593-b603-3786439564c5
          © 2011 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
          History

          Comments

          Comment on this article